BioLargo’s subsidiary Clyra Medical secures over $1 million in direct investments
BioLargo’s subsidiary Clyra Medical secures over $1 million in direct investments to finalize the acquisition of the breakthrough stem...
Search
alex25890
- Dec 20, 2018
- 3 min
BioLargo acquires breakthrough stem cell therapy technology to expand medical product portfolio
WESTMINSTER, Calif., Oct. 02, 2018 (GLOBE NEWSWIRE) -- BioLargo, Inc. (BLGO), developer of sustainable science and technologies and a...
273 views0 comments